期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
血清miR-208a在急性心肌梗死早期及急诊PCI前后表达的研究 被引量:11
1
作者 刘新秀 葛智儒 赵汉君 《中国循证心血管医学杂志》 2016年第6期718-720,共3页
目的探讨血清微小核糖核酸mi R-208a在急性心肌梗死(AMI)早期及急诊经皮冠状动脉介入(PCI)治疗前后表达的变化。方法选择急性心肌梗死患者30例作为AMI组,选择同期健康体检者20例(均无心脏疾病)作为对照组。AMI患者分别在入院即刻和入院... 目的探讨血清微小核糖核酸mi R-208a在急性心肌梗死(AMI)早期及急诊经皮冠状动脉介入(PCI)治疗前后表达的变化。方法选择急性心肌梗死患者30例作为AMI组,选择同期健康体检者20例(均无心脏疾病)作为对照组。AMI患者分别在入院即刻和入院后12 h(PCI术后6 h内)采集血液,健康对照组于清晨空腹采血,观察AMI患者发病早期血清mi R-208a的表达水平,将mi R-208a与肌钙蛋白I、肌酸激酶同工酶表达水平进行相关性分析,并比较AMI患者冠脉介入治疗前后血清mi R-208a的表达变化。结果 AMI患者血清mi R-208a水平显著高于对照组(P<0.05),急性心梗患者血清mi R-208a水平与肌钙蛋白I、肌酸激酶同工酶含量呈正相关(r1=0.356,P=0.045;r2=0.456,P=0.011),AMI患者冠脉介入治疗后血清mi R-208a水平较入院即刻显著降低(P<0.05)。结论血清mi R-208a在AMI患者早期表达显著升高,PCI后mi R-208a表达显著降低。 展开更多
关键词 miR-208a 心肌梗死 肌钙蛋白I 肌酸激酶同工酶
下载PDF
Direct ambulance transport to catheterization laboratory reduces door-to-balloon time in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the DIRECT-STEMI study 被引量:7
2
作者 QIU Jian-ping ZHANG Qi +5 位作者 LU Ji-de WANG Hai-rong LIN Jie ge zhi-ru ZHANG Rui-yan SHEN Wei-feng 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第6期805-810,共6页
Background Primary percutaneous coronary intervention (PCI) has been clearly identified as the first therapeutic option for patients with acute ST-segment elevation myocardial infarction (STEMI). The importance of... Background Primary percutaneous coronary intervention (PCI) has been clearly identified as the first therapeutic option for patients with acute ST-segment elevation myocardial infarction (STEMI). The importance of reducing door-to-balloon (D2B) time has gained increased recognition. This study aimed to assess the feasibility, safety and efficacy of the strategy of direct ambulance transportation of patients with acute STEMI to catheterization lab to receive primary PCI.Methods The study population included 141 consecutive patients with chest pain and ST-segment elevation who were admitted to the catheterization laboratory directly by the ambulance and underwent primary PCI (DIRECT group).Another 145 patients with STEMI randomly selected from the PCI database, were served as control group (conventional group); they were transported to catheterization laboratory from emergency room (ER). The primary endpoint of D2B time,and secondary endpoint of in-hospital and 30-day major adverse cardiac events (MACE, including death, non-fatal reinfarction, and target vessel revascularization) were compared.Results Baseline and procedural characteristics between the two groups were comparable, except more patients in the DIRECT group presented TIMI 0-1 flow in culprit vessel at initial angiogram (80.1% and 73.8%, P=0.04). Comparing to conventional group, the primary endpoint of D2B time was reduced ((54±18) minutes and (112±55) minutes, P 〈0.0001)and the percentage of patients with D2B 〈90 minutes was increased in the DIRECT group (96.9% and 27.0%, P〈0.0001).The success rate of primary PCI with stent implantation with final Thrombolysis in Myocardial Infarction (TIMI) 3 flow was significantly higher in the DIRECT group (93.8% and 85.2%, P=0.03). Although no significant difference was found at 30-day MACE free survival rate between the two groups (95.0% and 89.0%, P=0.06), a trend in improving survival status in the DIRECT group was demonstrated by Kaplan-Meier analysis.Conclusion Direct ambulance transport of STEMI patients to the catheterization laboratory could significantly reduce D2B time and improve success rate of primary PCI and 30-day clinical outcomes. 展开更多
关键词 acute myocardial infarction percutaneous coronary intervention STENT outcome door-to-balloon time
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部